BioCentriq Capacity Update February 2024: Cell & Gene

Source: BioCentriq

This presentation form the February 2024 OPCU event offers a comprehensive snapshot of BioCentriq, a leading Contract Development and Manufacturing Organization (CDMO) for cell therapy. Highlighting its global footprint and expertise, BioCentriq showcases its state-of-the-art facilities, established track record in GMP drug product release, and customized solutions supported by a seasoned team with strong commitment to quality. BioCentriq spearheads advancements in CAR-T manufacturing and accelerates clinical development timelines through its innovative LEAP platform, playing a notable role in advancing the accessibility and affordability of cell therapy.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma